Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV conivaptan dose-escalation study in cirrhotic patients
2007-001661-15Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of conivaptan in Cirrhosis (3 arms), sponsored by Astellas Pharma. Primary endpoint: Change in portal pressure. Started Sep 2007; status: completed.
02
Drugs
conivaptan
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2007-001661-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001661-15.